Title Associate Professor of Anaesthesia Institution Brigham and Women's Hospital Address Brigham and Women's Hospital
Btm7002f
60 Fenwood Rd
Boston MA 02115
|
|
Biography
2011
NIH Pathway to Independence Award (K99/R00)
2013
Movember-PCF Challenge Award
2014
PCF Young Investigator Award
2018
DoD LCRP Concept Award
2019
DoD PRCRP Idea Award with Special Focus
2019
ALA Lung Cancer Discovery Award
2021
Elected Fellow of the AIMBE
2021
MGB Innovation Discovery Award
2022
Clarivate Highly Cited Researcher
Overview
Our laboratory has a broad interest in nanomedicine, biomaterials, RNA therapy, immunotherapy, and antioxidative therapy for transformative biomedical applications. We are currently working on i) RNAi delivery for gene silencing; ii) mRNA delivery for protein replacement; iii) nanoparticle-mediated immune modulation; and iv) development of stimuli-responsive nanomaterials and bioinspired antioxidative polymers.
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R01HL159012
(SHI, JINJUN)
Jul 1, 2021 - Jun 30, 2025
Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance
Role: Principal Investigator
-
R01HL156362
(CHEN, HONG)
Dec 15, 2020 - Nov 30, 2024
The role of signaling adaptor protein epsin in atherosclerosis
Role: Co-Principal Investigator
-
R01HL127464
(TABAS, IRA A)
Jan 1, 2016 - Dec 31, 2020
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics
Role: Co-Principal Investigator
-
R01CA200900
(SHI, JINJUN)
Dec 21, 2015 - Jun 30, 2026
Systemic RNA Delivery to Tumors
Role: Principal Investigator
-
R00CA160350
(SHI, JINJUN)
Aug 1, 2013 - Jul 31, 2017
Nanoparticle Co-delivery of RNAi and Chemotherapy for Multidrug Resistant Cancers
Role: Principal Investigator
-
K99CA160350
(SHI, JINJUN)
Aug 1, 2011 - Jul 31, 2013
Nanoparticle Co-delivery of RNAi and Chemotherapy for Multidrug Resistant Cancers
Role: Principal Investigator
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.